AudioScholar Cardiology Weekly

AudioScholar Cardiology Weekly

AudioScholar
Country USA
Language EN-US
Episodes 4
Latest 17.11.2026

Cardiology — a weekly podcast briefing of the most significant peer-reviewed cardiology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Episodes

  • Biatrial maze beats LA maze in AF, without more pacemakers
    Biatrial maze beats LA maze in AF, without more pacemakers 17.11.2026 10m
    Editor's Pick: Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial (Circulation, 2026) This AudioScholar briefing is generated by artificial intelligence from PubMed abstracts for healthcare professionals and is not medical advice. This week's papers: 1. Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial.. Circulation 2026. 2. Angiography-Derived vs Wire-Based Fractional Flow Reserve to Guide Revascularization: The Randomized LIPSIA-STRATEGY Trial...
  • LBB pacing beats RV in atrioventricular block at interim
    LBB pacing beats RV in atrioventricular block at interim 10.11.2026 8m
    Editor's Pick: Left Bundle-Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block (New England Journal of Medicine, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning two high-profile failures and two successes in preventive targets, new mechanistic and long-term data in heart failure with preserved ejection fraction and amyloi… This week's papers: 1. Pelacarsen and Cardiovascular Outcomes in Patient...
  • TAVR in moderate aortic stenosis cuts HF events, not deaths
    TAVR in moderate aortic stenosis cuts HF events, not deaths 03.11.2026 11m
    Editor's Pick: TAVR in Patients with Moderate Aortic Stenosis with At-Risk Features (New England Journal of Medicine, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning earlier and broader use of structural heart intervention, how we image, diagnose and lower lipids in coronary disease, and new directions in conduction system pac… This week's papers: 1. TAVR in Patients with Moderate Aortic Stenosis with At-Risk Featu...
  • High coronary calcium at 30–45 tied to higher mortality
    High coronary calcium at 30–45 tied to higher mortality 27.10.2026 11m
    Editor's Pick: Advanced Subclinical Atherosclerosis in Young Individuals and Risk of Mortality Over 30 Years: The Coronary Artery Calcium Consortium (JAMA Cardiology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning cardiovascular prevention and risk stratification across the life course, therapeutic signals in heart failure and cardiomyopathy, and timing and technique in acu… This week's papers: 1. A Female-Specifi...
  • Subcutaneous furosemide adds ~4 days alive out of hospital
    Subcutaneous furosemide adds ~4 days alive out of hospital 20.10.2026 11m
    Editor's Pick: Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure (Journal of the American College of Cardiology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning faster and leaner acute care pathways, structural and valvular disease in older and frailer patients, and sharper risk stratification backed by a cluster of new s… This week's papers: 1. ICare-FASTER (Improving Care by...
  • BP lowering cuts cardiovascular events with or without CKD
    BP lowering cuts cardiovascular events with or without CKD 13.10.2026 10m
    Editor's Pick: Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease: A Systematic Review and Meta-Analysis (JAMA Cardiology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning heart failure therapy and device strategy, coronary plaque and intravascular imaging, and cardiovascular risk across blood pressure, the atrium, the liver and a w… This week's papers: 1. Biventricular v...
  • Orforglipron non-inferior to glargine for CV events in T2D
    Orforglipron non-inferior to glargine for CV events in T2D 06.10.2026 10m
    Editor's Pick: Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial (The Lancet, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning the cardiovascular-kidney-metabolic continuum, acute triage, surgery and transplant surveillance, and a cluster o...
  • Noncardiac surgery CV guideline: 2026 update replaces 2014
    Noncardiac surgery CV guideline: 2026 update replaces 2014 29.09.2026 10m
    Editor's Pick: 2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (Circulation, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning perioperative and procedural decision-making, risk stratification with imaging in valve and ischa...
  • Tenecteplase ICH in MI rises with systolic BP
    Tenecteplase ICH in MI rises with systolic BP 22.09.2026 11m
    Editor's Pick: Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction (European Heart Journal, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning risk prediction at the bedside, imaging biomarkers for prevention, and long-term outcomes after cardiac surgery and structural intervention. Let's dive in. This week's papers: 1. Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction.. European Heart Journal 2026. 2. European Infective Endocarditis (EURO-ENDO) score for predicting 30...
  • MCS in elective high-risk PCI doesn't improve CV outcomes
    MCS in elective high-risk PCI doesn't improve CV outcomes 15.09.2026 13m
    Editor's Pick: Mechanical Circulatory Support for Complex High-Risk Indicated Percutaneous Coronary Intervention: Network Meta-Analysis of Randomized Trials (Journal of the American Heart Association, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning acute coronary care and mechanical support, the diagnosis and treatment of heart failure with preserved ejection fraction, and a cluster of studies on cardiovascu… This week's papers: 1. Clinical Management of Myocardial Infarction.. Circulation 2026. 2. Mechanical Circulatory Support for Complex High-Ri...
  • Intravascular ultrasound: no cardiac death cut outside Asia
    Intravascular ultrasound: no cardiac death cut outside Asia 08.09.2026 11m
    Editor's Pick: Geographic heterogeneity in outcomes of intravascular ultrasound-guided vs angiography-guided percutaneous coronary intervention: a meta-analysis of randomized trials (European Heart Journal, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning revascularisation — from the operating theatre to the cath lab — heart failure and decongestion, and risk stratification across arrhythmia, valve disease and occu… This week's papers: 1. Long-Term Outcomes Following Bilateral vs Single Internal Thoracic Artery Grafts: A Secondary Analysis of a Rand...
  • Tricuspid repair ~halves 3-year death or HF admission
    Tricuspid repair ~halves 3-year death or HF admission 01.09.2026 12m
    Editor's Pick: Tricuspid-Valve Intervention in Heart Failure (New England Journal of Medicine, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning structural heart intervention, revascularization and imaging strategy in coronary disease, antithrombotic therapy after acute coronary syndromes, device-based rhy… This week's papers: 1. Tricuspid-Valve Intervention in Heart Failure. New England Journal of Medicine 2026. 2. Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation. New England Journal of Medicine 2026. 3. Complete Revascul...
  • Clopidogrel alone in diabetes cuts bleeds, no more ischemia
    Clopidogrel alone in diabetes cuts bleeds, no more ischemia 25.08.2026 11m
    Editor's Pick: Clopidogrel Versus Dual-Antiplatelet Therapy for Long-Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT-BIRISK Trial (Journal of the American Heart Association, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning antithrombotic and structural decisions in atrial fibrillation and valve surgery, lipid management and residual risk, and a set of practical clinical reviews on s… This week's papers: 1. Vasoactive Agent Select...
  • Finerenone benefit in HF holds with resistant hypertension
    Finerenone benefit in HF holds with resistant hypertension 18.08.2026 11m
    Editor's Pick: Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction (European Journal of Heart Failure, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning risk stratification with biomarkers and body measurements, imaging to guide decisions in chest pain and cardiomyopathy, and therapeutics ranging from finerenone i… This week's papers: 1. Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.. European Journal...
  • DOACs in mitral stenosis AF: higher stroke, no bleeding edge
    DOACs in mitral stenosis AF: higher stroke, no bleeding edge 11.08.2026 11m
    Editor's Pick: Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis: A Target Trial Emulation (Annals of Internal Medicine, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning heart failure — from what actually drives the benefit of our drugs to how outcomes have changed over a decade — plus anticoagulation and thrombotic risk in two ve… This week's papers: 1. Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement:...
  • Hypertrabeculation not prognostic in dilated cardiomyopathy
    Hypertrabeculation not prognostic in dilated cardiomyopathy 04.08.2026 10m
    Editor's Pick: Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy (Circulation, 2026) Welcome to This Week in Cardiology. This week we're covering nine notable papers spanning interventional and surgical revascularisation, cardiomyopathy imaging and pharmacotherapy, and the harder questions of anticoagulation, mechanical support, and… This week's papers: 1. Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised co…. Lancet 2026. 2. Left Ventricular Hypertrabeculation a...
  • This Week in Cardiology — Jul 31, 2026
    This Week in Cardiology — Jul 31, 2026 31.07.2026 12m
    Editor's Pick: Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial (JAMA, 2026) Welcome to This Week in Cardiology. This week we're covering six notable papers spanning advanced surgical and interventional outcomes, tailored pharmacotherapy in heart failure phenotypes, and the management of structural heart disease. This week's papers: 1. Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA 2026. 2. Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active c...
  • This Week in Cardiology — Jul 20, 2026
    This Week in Cardiology — Jul 20, 2026 21.07.2026 9m
    Editor's Pick: Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization (JAMA Internal Medicine, 2026) Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning major updates in lipid and preventive guidelines, new insights into heart failure management and phenotyping, and advances in vascular and coronary interventions.… This week's papers: 1. Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy. JAMA 2026. 2. Global Cardiology Groups Issue New Universal Definition of Heart...
  • This Week in Cardiology — Jul 13, 2026
    This Week in Cardiology — Jul 13, 2026 14.07.2026 9m
    Editor's Pick: Longitudinal Changes in Frailty and Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease (Journal of the American Heart Association, 2026) Welcome to This Week in Cardiology. This week we're covering nine notable papers spanning advanced heart failure management, novel cardiovascular risk factors, and evolving frameworks for lifelong care. Let's dive in. This week's papers: 1. Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.. Circulation 2026. 2. Com...
  • This Week in Cardiology — Jul 8, 2026
    This Week in Cardiology — Jul 8, 2026 08.07.2026 8m
    Editor's Pick: Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial (Lancet, 2026) Welcome to This Week in Cardiology. This week we're covering notable publications spanning advanced risk stratification in heart failure and hypertrophic cardiomyopathy, anticoagulation strategies in mechanical circulatory support, and the clinical n… This week's papers: 1. Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weig...

Popular in

The podcast also appears in the podcast charts of these countries.